MENU

Gynecological Oncology Fellowship

Program Director:
Christina S. Chu, MD, FACOG

Current Fellows:
Jennifer Brown, MD
Daniel Benrubi, MD
Maureen Roberts, MD

Fellowship  

The Gynecologic Oncology Fellowship is approved by the American Board of Obstetrics and Gynecology and now accredited by the ACGME.

The Division of Gynecologic Oncology at Fox Chase Cancer Center and Temple University Hospital offers a three-year fellowship for applicants who have completed an approved obstetrics and gynecology residency program.

The Division's mission is to train outstanding fellows who will become the future generation of leaders in academic gynecologic oncology. Our program is accredited by the American Board of Obstetrics and Gynecology and will be participating in the NRMP Match for July 2016. The program will accept one fellow each year for a three-year program.

Our Gynecologic Oncology Fellowship takes advantage of the combined resources of two of Philadelphia's most well-established academic medical centers to provide an outstanding and diverse educational experience for fellows.

Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Temple University Hospital is the major clinical training site for the Lewis Katz School of Medicine at Temple University. The Hospital is a large urban academic medical center which sees over 35,000 inpatient admissions a year.

About the Program

The first year of the fellowship will be dedicated to research activities. The program director will work with the incoming fellows prior to their official arrival on campus to determine their specific research interests and prior experience. The fellowship director will select 3-5 potential research mentors, based on the fellow's expressed interests, the investigators' mentorship abilities, and availability of projects. The fellow and proposed mentors will communicate and teleconference prior to July 1st to allow final selection of a project—it is expected that a good fit for a fellow-mentor relationship will be formed prior to the start date of their first year in order to help maximize the potential for a successful experience.

Fellows are expected to participate in, present and publish results of research which can include basic science, translational, outcomes or clinical trial data.

The second and third years of the fellowship consist of monthly clinical rotations divided between the Fox Chase and Temple campuses, which are separated by 7 miles. Fellows will participate fully in prescribing and ordering chemotherapy, as well as consultation and planning for radiation therapy. In addition, August of the second year will be spent in an off-service rotation in the Temple University Hospital Surgical Intensive Care Unit, a 25-bed unit accredited as a Regional Resource Level 1 Trauma Center, providing both excellence in clinical care, as well as educational experience. An additional off-service rotation on the Gastrointestinal Surgery Service at Fox Chase will occur in September of the third year where the fellow will function as the senior member of the team and the primary assistant to the attending GI surgeons.

Meetings and Conferences

The Division maintains a full schedule of educational conferences, including weekly didactic lectures, tumor board, and departmental M and M and Grand Rounds. Gynecologic Oncology Research Group and Translational Research Disease Group meetings are also held monthly to facilitate research collaborations and progress in clinical trials. In addition to receiving formal training in cancer surgery, fellows are exposed to tumor biology, biostatistics, research design and methodology.

Eligibility

Prospective candidates must have successfully completed an ACGME approved residency in obstetrics and gynecology, have passed the USMLE, FMGEMS, TOEFL or FLEX exams, and be able to secure a Pennsylvania medical license.

Application Process

Applications to the fellowship will be accepted through ERAS, the Electronic Residency Application Service.

All applications should be completed and submitted electronically by April 2.

All applications through ERAS must include:

  • Completed online application
  • Current curriculum vitae
  • Personal Statement
  • Three current letters of recommendation (one from program director)
  • Official transcripts for all applicable examinations (USMLE Step I and II, LMCC, COMLEX, NBOME, FMGEMS, FLEX or NBME)
  • CREOG scores
  • Recent photograph

Contact Information

For further information regarding the application process, please contact:

Jaclyn Feeney
Lead Program Administrator
Temple University Hospital
3401 N. Broad Street
Outpatient Building, Zone B
Sixth Floor, Room 612
Philadelphia, PA 19140
Phone: 215-707-3187
Fax: 215-707-5108
Email: jaclyn.feeney@tuhs.temple.edu

About Fox Chase Cancer Center

Fox Chase Cancer Center is an NCI-designated Comprehensive Cancer Center. The Center includes a 100-bed hospital devoted entirely to cancer patients, an outpatient center which includes a facility for clinical cancer prevention and research, one of the oldest and most nationally recognized high risk programs in the country, and the Institute for Cancer Research. The Women’s Cancer Facility, enclosed within the Center’s $67 million new clinical outpatient building, opened in March 2010. The Center has a residency in radiation oncology, as well as fellowship programs in a variety of areas, including medical oncology and urologic oncology. The Center is also home to an SSO-approved General Surgical Oncology Fellowship. Residents from Temple University's Lewis Katz School of Medicine and other regional institutions also rotate at the Center.

About Temple University Health System

Temple University Health System (TUHS) is a $1.6 billion academic health system dedicated to providing access to quality patient care and supporting excellence in medical education and research.   The Health System consists of Temple University Hospital (TUH), ranked among the “Best Hospitals” in the region by U.S. News & World Report; TUH-Episcopal Campus; TUH-Northeastern Campus; Fox Chase Cancer Center, an NCI-designated comprehensive cancer center;  Jeanes Hospital, a community-based hospital offering medical, surgical and emergency services; Temple Transport Team, a ground and air-ambulance company; and Temple Physicians, Inc., a network of community-based specialty and primary-care physician practices.  TUHS is affiliated with the Lewis Katz School of Medicine at Temple University.

The Lewis Katz School of Medicine at Temple University (LKSOM), established in 1901, is one of the nation’s leading medical schools.  Each year, the School of Medicine educates approximately 840 medical students and 140 graduate students. Based on its level of funding from the National Institutes of Health, Temple University School of Medicine is the second-highest ranked medical school in Philadelphia and the third-highest in the Commonwealth of Pennsylvania.  According to U.S. News & World Report, LKSOM is among the top 10 most applied-to medical schools in the nation.

Temple Health refers to the health, education and research activities carried out by the affiliates of Temple University Health System (TUHS) and by the Lewis Katz School of Medicine at Temple University.  TUHS neither provides nor controls the provision of health care. All health care is provided by its member organizations or independent health care providers affiliated with TUHS member organizations. Each TUHS member organization is owned and operated pursuant to its governing documents.